Please click on the ID to see detailed information about each entry.
The total number entries retrieved from this search areID1009 | SequenceRRRRRRRRRRRLILV LLAI | Name11R-No. 10 | Nature of peptide or cargoMelanogenesis inhibitory peptide | AssayConfocal microscope | Tissue permeabilityWhen TMR-11R was topically applied for 24 h, the signals were only observed on the surface of the skin. In contrast, 12 h later, strong signals were detected showing that TMR-11R had arrived at the skin basal layer. Moreover, 24 and 48 hours later, the signals had spread out more and were stronger in both epidermis and dermis | Tissue SampleSkin from the back of a brown guinea pig | PUBMED ID24602570 |
ID1016 | SequenceGKKKKKKKRRRRRRRR | NameR16 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 21.43 ± 1.32 , Q48 (mg) 856.29 ± 39.50 Drug content in skin (mg/cm2) 151 ± 4.64 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1017 | SequenceGKKKKKKKRRRRRRRR | NameR16 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 23.46 ± 2.04 , Q48 (mg) 1106.03 ± 53.80 Drug content in skin (mg/cm2) 155 ± 4.85 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1018 | SequenceGKKKKKKKRRRRRRRR | NameR16 (arginine-terminated peptide dendrimers) | Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groups | AssayFranz diffusion cell | Tissue permeabilityFlux (mg/cm2/h) 27.16 ± 2.65, Q48 (mg) 1256.61 ± 55.70, Drug content in skin (mg/cm2) 156 ± 6.26 | Tissue SampleHuman epidermal skin | PUBMED ID24134794 |
ID1023 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell | Tissue permeabilityTP could not pass through the skin due to the charge repulsion effect between the negative charge of the TP and the negative charge of the skin | Tissue SampleAbdominal skin of Sprague–Dawley rats | PUBMED ID23311648 |
ID1024 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell | Tissue permeabilityCumulative amounts0.10± 0.01 µg/cm2 and fluxes 0.60 ± 0.06 µg/cm2·h | Tissue SampleAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley rats | PUBMED ID23311648 |
ID1025 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell | Tissue permeabilityCumulative amounts 0.31 ± 0.04 µg/cm2 and fluxes 1.86 ± 0.24 µg/cm2·h | Tissue SampleAbdominal skin of Sprague–Dawley rats | PUBMED ID23311648 |
ID1026 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell | Tissue permeabilityCumulative amounts 1.02 ± 0.05 µg/cm2 and fluxes 6.13± 0.28 µg/cm2·h | Tissue SampleAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley rats | PUBMED ID23311648 |
ID1027 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell | Tissue permeabilityCumulative amounts 4.29 ± 0.40 µg/cm2 and fluxes 25.73 ± 2.40 µg/cm2·h | Tissue SampleAbdominal skin of Sprague–Dawley rats | PUBMED ID23311648 |
ID1077 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell, HPLC | Tissue permeabilityCumulative amounts 0.20 ± 0.05 mg/cm2 and fluxes 0.20 ± 0.05 mg/cm2·h | Tissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) rats | PUBMED ID22564052 |
ID1078 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell, HPLC | Tissue permeabilityCumulative amounts 0.43 ± 0.04 mg/cm2 and fluxes 0.14 ± 0.01 mg/cm2·h | Tissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) rats | PUBMED ID22564052 |
ID1079 | SequenceGRKKRRQRRRPPQRKC | NameTat | Nature of peptide or cargoCell penetrating peptide | AssayVertical Franz diffusion cell, HPLC | Tissue permeabilityCumulative amounts 0.59 ± 0.12 mg/cm2 and fluxes 0.10 ± 0.02 mg/cm2·h | Tissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) rats | PUBMED ID22564052 |
ID1083 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayFranz diffusion cell system, HPLC with photodiode array detector | Tissue permeability2-fold higher | Tissue SamplePorcine ear skin | PUBMED ID22306174 |
ID1084 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayFranz diffusion cell system, HPLC with photodiode array detector | Tissue permeability2.8 wt% of the initial amount | Tissue SamplePorcine ear skin | PUBMED ID22306174 |
ID1085 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayThe scotch tape method | Tissue permeability0.35 wt% of Na-DFC | Tissue SampleSC skin | PUBMED ID22306174 |
ID1086 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayThe scotch tape method | Tissue permeability0.72 wt% of Na-DFC | Tissue SampleSC skin | PUBMED ID22306174 |
ID1087 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayThe scotch tape method | Tissue permeability0.3 wt% of Na-DFC | Tissue SampleE + D skin | PUBMED ID22306174 |
ID1088 | SequenceRQIKIWFQNRRMKWKK | NamePenetratin (PEN) | Nature of peptide or cargoPenetrate through cell and nucleus membranes | AssayThe scotch tape method | Tissue permeability0.57 wt% of Na-DFC | Tissue SampleE + D skin | PUBMED ID22306174 |
ID1104 | SequenceKWLNALLHHGLNCAK GVLA | NameHG1 | Nature of peptide or cargoAntimicrobial | AssayConfocal microscopy, HPLC | Tissue permeabilitySignificant permeability of the peptide can be seen in confocal images | Tissue SampleICR mice skin | PUBMED ID21220538 |
ID1105 | SequenceACSSSPSKHCGGRRR RRRRR | NameTD1-R8 | Nature of peptide or cargoMITF-siRNA inhibition of melanin synthesis and melanoma cell apoptosis. | AssayLaser scanning confocal microscopy | Tissue permeabilitySignificant penetration of carboxyfluorescein-labeled MITF-siR can be seen in confocal images of whole epidermis and partial dermis | Tissue SampleHair shaved back of BALB/c mice | PUBMED ID21119619 |
ID1106 | SequenceACSSSPSKHCGGRRR RRRRR | NameTD1-R8 | Nature of peptide or cargoMITF-siRNA inhibition of melanin synthesis and melanoma cell apoptosis. | AssayReal-time PCR | Tissue permeabilityThe cream penetrated the mouse skin and mouse skin exhibited a 52% and 34% decrease in MITF and TYR mRNA levels, respectively (versus naive control). | Tissue SampleHair shaved back of BALB/c mice | PUBMED ID21119619 |
ID1108 | SequenceRALARALARALRALAR | NameRALA | Nature of peptide or cargoBased on a family of amphipatic peptides that exhibit improved membrane permeability belongs to a synthetic family of CPEs. | AssayFranz diffusion cell, HPLC | Tissue permeability60% of applied dose | Tissue SampleStratum corneum of ear of porcine | PUBMED ID20189781 |
ID1114 | SequenceFLGGLIKIVPAMICA VTKKC | NameRanalexin | Nature of peptide or cargoAntimicrobial | AssayFranz diffusion cell | Tissue permeabilityIn combination these compounds reduced viable bacteria by 2.83 ± 0.26 log10 CFU | Tissue SampleAbdominal skin from a 38-year-old white female donor | PUBMED ID19709343 |
ID1115 | SequenceFLGGLIKIVPAMICA VTKKC | NameRanalexin | Nature of peptide or cargoAntimicrobial | AssayFranz diffusion cell | Tissue permeabilityRanalexin (100 mg l-1) reduced viable MRSA252 by 0.13 ± 0.06 log10 CFU | Tissue SampleAbdominal skin from a 38-year-old white female donor | PUBMED ID19709343 |
ID1140 | SequenceTRWYSMKKTTMKIIP FNRL | NameHaptide | Nature of peptide or cargoImprove the cell penetration and subsequent presentation of the antigen. | AssayAnti-LT antibodies determination by ELISA | Tissue permeabilitySignificant increase in antibody titer (anti-LT) in the serum of mice on topical application with HR-gp100H | Tissue SampleEars of BALB/c mice | PUBMED ID17493711 |
ID1188 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayELISA | Tissue permeabilityLog10 antibody titres=2.7 after first booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1189 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayELISA | Tissue permeabilityLog10 antibody titres=3.8 after second booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1190 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayELISA | Tissue permeabilityLog10 antibody titres=4.5 after third booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1191 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayNeutralisation assay | Tissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.5 after first booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1192 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayNeutralisation assay | Tissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.1 after second booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1193 | SequenceCGSGVRGDFGSLAPR VARQL | NamePeptide 141–159 from the VP1 protein of serotype A12 | Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisation | AssayNeutralisation assay | Tissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.7 after third booster | Tissue SampleAbdominal skin of BALB/c mice | PUBMED ID15734548 |
ID1392 | Sequencelsaydpvdypysnsfakc | NameRetro-inverso HA 91-108 | Nature of peptide or cargoAntigenic properties with increased resistance to proteolytic activity and consequently longer persistence in vivo | AssayELISA | Tissue permeabilityRetro-inverso peptide induced high levels of serum IgG and lung IgA antibodies | Tissue SampleNasal cavity of mouse | PUBMED ID12220890 |